Physician profile
Jorge Ramirez
NPI 1205808771
$1,846.19
in general payments reported to CMS, 2019-2025
14 companies · $500 in 2025
The $500 reported for 2025 was more than what 76% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2021: $278 · 2022: $501 · 2023: $213 · 2024: $210 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910 · Education: $13.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.36 |
| Education | $13.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $398.40 | 2023-2025 | Aquadex Smartflow Console |
| Alexion Pharmaceuticals, INC. | $335.10 | 2021-2023 | |
| Integra Lifesciences Corporation | $151.43 | 2022 | |
| Calliditas Therapeutics US INC. | $124.70 | 2025 | Tarpeyo |
| Rhythm Pharmaceuticals, INC. | $124.60 | 2022 | |
| Apellis Pharmaceuticals, INC. | $120.06 | 2025 | Empaveli |
| Aurinia Pharma U.S., INC. | $117.77 | 2021 | |
| Salvin Dental Specialties, INC. | $113.96 | 2019 | |
| Alnylam Pharmaceuticals INC. | $106.84 | 2022 | |
| Kyowa Kirin, INC. | $89.46 | 2024 | Crysvita |
| Stryker Corporation | $77.74 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Abiomed | $39.27 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $30.00 | 2019 | |
| Travere Therapeutics, INC. | $16.86 | 2022-2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.